We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OMIC market cap is 27.15M. The company's latest EPS is USD -1.2921 and P/E is -0.29.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 765k | 863k | 505k | 462k | 1.08M |
| Operating Income | -22.53M | -25.38M | -27.6M | -24.54M | -25.28M |
| Net Income | -21.1M | -23.63M | -25.58M | -22.36M | -23.25M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 765k | 2.91M |
| Operating Income | -12.77M | -27.53M | -61.28M | -93.49M | -102.8M |
| Net Income | -12.32M | -27.95M | -98.77M | -90.88M | -94.82M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 327.98M | 305.47M | 283.98M | 284.52M | 265.47M |
| Total Liabilities | 67.65M | 65.14M | 65.59M | 85.49M | 86.46M |
| Total Equity | 260.32M | 240.33M | 218.39M | 199.03M | 179.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 48.17M | 30.5M | 355.65M | 327.98M | 265.47M |
| Total Liabilities | 3.69M | 12.87M | 19.48M | 67.65M | 86.46M |
| Total Equity | -24.73M | -51.56M | 336.17M | 260.32M | 179.01M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -87.09M | -17.93M | -37.93M | -54.75M | -73.65M |
| Investing | -39.57M | 72.95M | 37.86M | 13.16M | 13.81M |
| Financing | 901k | 6k | 624k | 624k | 696k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.4M | -24.87M | -51.7M | -87.09M | -73.65M |
| Investing | -31.5M | 24.01M | -130.86M | -39.57M | 13.81M |
| Financing | 47.3M | 7.52M | 372.13M | 901k | 696k |
| Market Cap | 27.15M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 9.32 |
| Price to Cash Ratio | 1.67 |
| Price to Book Ratio | 0.15 |
| Dividend Yield | - |
| Shares Outstanding | 73.38M |
| Average Volume (1 week) | 152.03k |
| Average Volume (1 Month) | 159.53k |
| 52 Week Change | -66.36% |
| 52 Week High | 1.14 |
| 52 Week Low | 0.3101 |
| Spread (Intraday) | 0.11 (23.4%) |
| Company Name | Singular Genomics Systems Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.singulargenomics.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
